Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within pathology.
Inify Laboratories has raised $9.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Inify Laboratories's investors include Monsun AS, Gallivant S.à r.l..
Inify Laboratories is headquartered in Stockholm, Sweden.
Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within pathology.
Inify Laboratories is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inify Laboratories — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/inify-laboratories. Accessed August 14, 2026.
VCBacked. (2025). Inify Laboratories — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/inify-laboratories
{{cite web |title=Inify Laboratories — Funding & Investors |url=https://www.vcbacked.co/company/inify-laboratories |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated